Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles via Google Scholar Search for Related Content

INDUSTRY-SUPPORTED LUNCH AND DINNER SYMPOSIA OCTOBER 6-8, 2004

7 p.m.-10 p.m.

The Role of Race and Ethnicity in Utilizing Atypical Antipsychotics

Chair: Henry Nasrallah, M.D.

Supported by AstraZeneca

Thursday, October 7

Noon-1:30 p.m.

Depression: Is Recovery an Achievable Goal? Part I

Chair: David Kupfer, M.D.

Supported by Eli Lilly and Company

Optimizing Patient Outcomes: Advances in the Use of Antipsychotics

Chair: Charles L. Bowden, M.D.

Supported by Pfizer

6 p.m.-9 p.m.

Covering the Bases for Supporting Bipolar Patients

Chair: Alan C. Swan, M.D.

Supported by GlaxoSmithKline

Friday, October 8

Noon-1:30 p.m.

Depression: Is Recovery an Achievable Goal? Part II

Chair: David Kupfer, M.D.

Supported by Eli Lilly and Company

Differential Diagnosis: A Different Approach to Insomnia

Chair: Ruth Benca, M.D.

Supported by King Pharmaceuticals

6 p.m.-9 p.m.

Beyond Sleep Onset: New Perspectives on the Treatment of Insomnia

Chair: Andrew Krystal, M.D.

Supported by Sepracor

Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles via Google Scholar Search for Related Content

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us